Feb. 2-Take Aim at Cancer Presents: Innovations in Lung Cancer Research, Treatment and Patient Care | Health
Leading MD Anderson Oncology Chief to Speak at The Lovett School at 7pm
ATLANTA (January 27, 2012) Lung cancer is the No. 1 cause of cancer-related death in both men and women in the U.S. according to the Centers for Disease Control and Prevention. In 2007 (most recent statistics), lung cancer accounted for more deaths than breast cancer, prostate cancer and colon cancer combined. But there’s good news: We’re closer than ever before to eradicating this deadly disease.
Take Aim at Cancer, a 501(c)(3) nonprofit organization benefiting targeted therapy and lung cancer research, is pleased to present this free educational event that is open to the public. It will be held on Thursday, February 2, 2012 from 7:00 p.m. to 8:00 p.m. at The Lovett School’s Hendrix-Chenault Theater at 4075 Paces Ferry Road, N.W., Atlanta, GA 30327.
Take Aim at Cancer’s Founder Jeffrey Wigbels, a Stage IV non-smokers lung cancer survivor and Atlanta wealth manager, will open the evening’s event with his personal story (visit TakeAimAtCancer.org to learn more.) Then he will introduce Dr. Edward Kim who will discuss Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE), a set of ground-breaking trials taking place at The University of Texas M. D. Anderson Cancer Center (MD Anderson). BATTLE has the potential to affect every type of malignancy, and is proving that targeted therapy may one day change the standard of care for cancer treatment.
Dr. Kim leads BATTLE and is Associate professor of Medicine, Chief of the Section of Head and Neck Medical Oncology, and Director of Clinical Research Operations in the Department of Thoracic/Head and Neck Medical Oncology at MD Anderson. He studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck as well as thymic cancers. Dr. Kim has published more than 100 original articles, reviews and abstracts in medical journals.
Complementing the Feb. 2 event, Take Aim at Cancer, in conjunction with The Lovett School, has also planned an educational program held exclusively for Lovett 10th, 11th and 12th grade students during science classes on Friday, Feb. 3. The day’s journey is designed to educate and inspire the students in the fields of research, science and medicine with the hope that some may become future doctors and researchers. The goal is for students to better understand unique ways of targeting the fight against cancer and to help prolong life through understanding.
This Take Aim at Cancer high school educational event at Lovett marks the second annual implementation of the program which was launched in February 2011 at The Westminster Schools in Atlanta. This program, co-chaired by Fontaine Draper and Barbara Levy, is made possible by the following individuals who contribute time and effort into educating others in the constant struggle to combat cancer include: Jeffrey and Tiffany Wigbels, Sara Chapman, Meade Conley, Judy Fehlenberg, Dr. Eric Mininberg, Dr. Amy Mininberg and Dr. Steve Wilks.
About Take Aim at Cancer
Take Aim at Cancer was founded in January 2010 by Jeffrey Wigbels. Take Aim at Cancer is an Atlanta-based 501(c)(3) nonprofit organization benefitting targeted therapy and lung cancer research. In May 2010, Wigbels was the recipient of MD Anderson’s “Making Cancer History” Award. Take Aim at Cancer’s mission is to raise critical funding for increased research, scientific collaboration and awareness of targeted cancer therapy, so that more people who are battling cancer can have the opportunity for this ground-breaking, personalized treatment and the chance for a brighter future. For more information or to make an online donation, visit TakeAimAtCancer.org. Check donations are always accepted, made payable to “Take Aim at Cancer.” Mail to Take Aim at Cancer, 931 Monroe Drive NE, Suite A-102 #158, Atlanta, GA 30308.